2006
DOI: 10.1016/j.clim.2006.06.006
|View full text |Cite
|
Sign up to set email alerts
|

The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
368
0
5

Year Published

2009
2009
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 472 publications
(374 citation statements)
references
References 86 publications
1
368
0
5
Order By: Relevance
“…The transferrin receptor is a crucial protein involved in iron homeostasis and the regulation of cell growth. The high levels of expression of transferring receptor in cancer cells, which may be up to 100-fold higher than the regular expression of normal cells, its extracellular DOI:http://dx.doi.org/10.7314/APJCP.2014.15.2.517 PLGA-Based Nanoparticles as Cancer Drug Delivery Systems accessibility, its ability to internalize and its central role in the cellular pathology of human cancer, make this receptor an attractive target for cancer therapy (Cho et al, 2008;Danhier et al, 2010;Daniels et al, 2006). ii) The folate receptor is a famous tumor marker that binds to the vitamin folic acid and folate-drug conjugates or folate grafted nanocarriers with a high affinity and carries these bound molecules into the cells through receptormediated endocytosis.…”
Section: The Targeting Of Cancer Cellmentioning
confidence: 99%
“…The transferrin receptor is a crucial protein involved in iron homeostasis and the regulation of cell growth. The high levels of expression of transferring receptor in cancer cells, which may be up to 100-fold higher than the regular expression of normal cells, its extracellular DOI:http://dx.doi.org/10.7314/APJCP.2014.15.2.517 PLGA-Based Nanoparticles as Cancer Drug Delivery Systems accessibility, its ability to internalize and its central role in the cellular pathology of human cancer, make this receptor an attractive target for cancer therapy (Cho et al, 2008;Danhier et al, 2010;Daniels et al, 2006). ii) The folate receptor is a famous tumor marker that binds to the vitamin folic acid and folate-drug conjugates or folate grafted nanocarriers with a high affinity and carries these bound molecules into the cells through receptormediated endocytosis.…”
Section: The Targeting Of Cancer Cellmentioning
confidence: 99%
“…The transferrin receptor (CD71) is a cell membrane-associated glycoprotein involved in iron homeostasis and cell growth. It has been explored as a target for delivering therapeutic agents into cancer cells, due to its increased expression on malignant cells, accessibility on the cell surface, and constitutive endocytosis (12)(13)(14). CD71 was also used here as it is always expressed in normal mesothelial cells, contributing to further identification and immunophenotyping with the basic panel (15).…”
Section: Discussionmentioning
confidence: 99%
“…CD71 was used as a marker to localize a suspicious CD45 negative cell population, which could be of malignant or other origin. Although it is not a common tumor marker, it is upregulated in proliferating cells (such as tumor cells) (12)(13)(14). It is also expressed by normal mesothelial cells (15), so it could operate as a linkage marker for their differential diagnosis.…”
Section: Flow Cytometric Gating Strategy Initial Panelmentioning
confidence: 99%
“…Since hTf is one of relatively few proteins that can be internalized by rapidly growing cells, it is an attractive candidate for various therapeutic strategies aiming at specific delivery of imaging and cytotoxic agents to neoplastic cells (4). It is therefore not surprising that the TfR-mediated uptake pathway has been a focus of extensive research in recent years.…”
Section: Metalloprotein | Protein Interactionmentioning
confidence: 99%